Trying to separate three different claims about CJC-1295: that it is the right molecule, that it is the right dose, and that it does something useful.
My rule now: if a claim cannot survive being written down with the numbers attached, it is marketing.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
The effect size I actually noticed is roughly a third of what the write-ups imply, and it took three weeks to be sure.
Cold storage, light protection, and a date on the vial. Boring, and it removes half the variables.
Water retention and mild lethargy in the first fortnight are the usual pattern.
What would change your mind about this?
Log dose, time and sleep. Ten seconds a day and it turns the anecdote into something you can look at.
Is a baseline blood test really necessary before starting something like this?
Sleep, food, or the compound? Yes. Same for me with CJC-1295, unfortunately.
Baseline first. Without a baseline the after picture is decoration.
Most of what is called evidence here is one person, one vial, one month.
Read methods.
Is a baseline blood test really necessary before starting something like this? Lethargy in the first fortnight was my main issue with CJC-1295 too.
Where does the human data stop and the extrapolation begin? That is the whole thread.
Same here.
How long before you can reasonably say something is or is not doing anything?
Reconstitution arithmetic is only half the problem. The other half is what was in the vial. Not on CJC-1295 but the pattern is familiar.
Same here.